• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低树突状细胞中 Mettl3 基因的外泌体可预防小鼠心脏移植模型中的免疫排斥反应。

Exosomes from dendritic cells with Mettl3 gene knockdown prevent immune rejection in a mouse cardiac allograft model.

机构信息

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University; Hubei Cardiovascular Medicine Clinical Research Center & Hubei Key Laboratory of Cardiology, 238# Jiefang Road, Wuchang District, Hubei Province, Wuhan, China.

Department of Critical Care Medicine, Jin Yin-tan Hospital, 1# Yin-Tan Road, Dongxihu District, Hubei Province, Wuhan, China.

出版信息

Immunogenetics. 2020 Oct;72(8):423-430. doi: 10.1007/s00251-020-01180-8. Epub 2020 Oct 3.

DOI:10.1007/s00251-020-01180-8
PMID:33009922
Abstract

We have previously demonstrated that Mettl3-silencing dendritic cells (DCs) exhibited immature properties and prolonged allograft survival in a murine heart transplantation model. Exosomes derived from donor DCs (Dex) are involved in the immune rejection of organ transplantation, and blocking Dex transfer may suppress immune rejection. Herein, this study aimed to investigate whether Mettl3 knockdown inhibits the secretion and activity of donor Dex, thereby inhibiting donor Dex-mediated immune rejection. The imDex, mDex, shCtrl-mDex, and shMettl3-mDex were obtained from the culture supernatant of DCs (immature DCs, mature DCs, shCtrl-infected mature DCs, shMettl3-infected mature DCs) derived from donor BALB/c mouse bone marrow and then co-cultured with splenic T cell lymphocyte suspension from recipient C57BL/6 mice in vitro or injected into recipient C57BL/6 mice before the cardiac transplantation. Donor shMettl3-mDex expressed lower concentration of exosomes and lower expression of Mettl3, Dex markers (ICAM-1, MHC-I, MHC-II), as well as lower ability to activate T cell immune response than shCtrl-mDex. Administration of donor shMettl3-mDex attenuated immune rejection after mouse heart transplantation and prolonged the allograft survival. In summary, Mettl3 knockdown inhibits the immune rejection of Dex in a mouse cardiac allograft model.

摘要

我们之前的研究表明,沉默 Mettl3 的树突状细胞(DC)表现出不成熟的特性,并延长了小鼠心脏移植模型中的同种异体移植物存活时间。供体 DC 来源的外泌体(Dex)参与器官移植的免疫排斥反应,阻断 Dex 的转移可能抑制免疫排斥反应。在此,本研究旨在探讨 Mettl3 敲低是否抑制供体 Dex 的分泌和活性,从而抑制供体 Dex 介导的免疫排斥反应。imDex、mDex、shCtrl-mDex 和 shMettl3-mDex 分别从供体 BALB/c 鼠骨髓来源的未成熟 DC(immature DC)、成熟 DC(mature DC)、shCtrl 感染的成熟 DC(shCtrl-infected mature DC)和 shMettl3 感染的成熟 DC(shMettl3-infected mature DC)的培养上清中获得,然后与来自受者 C57BL/6 鼠脾 T 细胞淋巴细胞悬液在体外共培养,或在心脏移植前注射到受者 C57BL/6 鼠体内。与 shCtrl-mDex 相比,供体 shMettl3-mDex 表达的外泌体浓度更低,Mettl3、Dex 标志物(ICAM-1、MHC-I、MHC-II)的表达水平更低,激活 T 细胞免疫反应的能力也更低。给予供体 shMettl3-mDex 可减轻小鼠心脏移植后的免疫排斥反应,并延长同种异体移植物的存活时间。综上所述,Mettl3 敲低可抑制小鼠心脏移植模型中 Dex 的免疫排斥反应。

相似文献

1
Exosomes from dendritic cells with Mettl3 gene knockdown prevent immune rejection in a mouse cardiac allograft model.敲低树突状细胞中 Mettl3 基因的外泌体可预防小鼠心脏移植模型中的免疫排斥反应。
Immunogenetics. 2020 Oct;72(8):423-430. doi: 10.1007/s00251-020-01180-8. Epub 2020 Oct 3.
2
Dendritic cells with METTL3 gene knockdown exhibit immature properties and prolong allograft survival.敲低 METTL3 基因的树突状细胞表现出未成熟的特性,并延长移植物的存活时间。
Genes Immun. 2020 May;21(3):193-202. doi: 10.1038/s41435-020-0099-3. Epub 2020 May 27.
3
Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model.未成熟树突状细胞来源的外泌体和雷帕霉素在小鼠心脏移植模型中的诱导耐受作用。
PLoS One. 2012;7(8):e44045. doi: 10.1371/journal.pone.0044045. Epub 2012 Aug 29.
4
Donor dendritic cell-derived exosomes promote allograft-targeting immune response.供体树突状细胞衍生的外泌体促进同种异体移植靶向免疫反应。
J Clin Invest. 2016 Aug 1;126(8):2805-20. doi: 10.1172/JCI84577. Epub 2016 Jun 27.
5
Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation.在心脏移植中使用环状RNA FSCN1沉默的树突状细胞预防同种免疫排斥反应。
J Heart Lung Transplant. 2021 Jul;40(7):584-594. doi: 10.1016/j.healun.2021.03.025. Epub 2021 Apr 8.
6
Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats.未成熟骨髓树突状细胞来源的外泌体诱导大鼠肠移植的免疫耐受。
J Surg Res. 2011 Dec;171(2):826-32. doi: 10.1016/j.jss.2010.05.021. Epub 2010 Jun 8.
7
Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.调节性 T 细胞表面 CD28/CTLA-4 的表达抑制耐受树突状细胞抑制小鼠角膜同种异体移植排斥反应。
Cell Biol Int. 2014 Jul;38(7):835-48. doi: 10.1002/cbin.10268. Epub 2014 Mar 14.
8
Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart.供体来源的外泌体诱导特异性调节性T细胞抑制同种异体移植心脏中的免疫炎症。
Sci Rep. 2016 Jan 29;7:20077. doi: 10.1038/srep20077.
9
Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.用于预防同种异体心脏移植排斥反应的治疗性树突状细胞和调节性T细胞的生成。
Clin Immunol. 2008 Jun;127(3):313-21. doi: 10.1016/j.clim.2008.01.013. Epub 2008 Mar 20.
10
GDF15 Regulates Malat-1 Circular RNA and Inactivates NFκB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation.GDF15 调节 Malat-1 环状 RNA 并使 NFκB 信号失活,从而诱导产生免疫耐受型树突状细胞,防止心脏移植中的同种异体免疫排斥反应。
Front Immunol. 2018 Oct 30;9:2407. doi: 10.3389/fimmu.2018.02407. eCollection 2018.

引用本文的文献

1
Regulatory Immune Cell-derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation.调节性免疫细胞衍生的外泌体:移植中的作用模式及治疗潜力
Transplantation. 2025 Jul 1;109(7):1124-1137. doi: 10.1097/TP.0000000000005309. Epub 2025 Jan 27.
2
METTL3: a multifunctional regulator in diseases.METTL3:疾病中的多功能调节因子
Mol Cell Biochem. 2025 Jan 24. doi: 10.1007/s11010-025-05208-z.
3
The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function.
甲基转移酶样蛋白 3 在免疫系统中的不可或缺性:从维持内稳态到驱动功能。
Front Immunol. 2024 Oct 2;15:1456891. doi: 10.3389/fimmu.2024.1456891. eCollection 2024.
4
Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.早期透明细胞肾细胞癌m6A RNA甲基化调节因子预后模型的构建与验证
Oncol Lett. 2022 Jun 10;24(2):250. doi: 10.3892/ol.2022.13370. eCollection 2022 Aug.
5
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH.表转录组学方法:通过共靶向细胞内检查点 CISH 提高 ICB 治疗的疗效。
Cells. 2021 Aug 30;10(9):2250. doi: 10.3390/cells10092250.
6
Expedition into Exosome Biology: A Perspective of Progress from Discovery to Therapeutic Development.外泌体生物学探索:从发现到治疗开发的进展视角
Cancers (Basel). 2021 Mar 8;13(5):1157. doi: 10.3390/cancers13051157.